GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » 5-Year Yield-on-Cost %

Afrocentric Investment (JSE:ACT) 5-Year Yield-on-Cost % : 2.62 (As of May. 23, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment 5-Year Yield-on-Cost %?

Afrocentric Investment's yield on cost for the quarter that ended in Dec. 2023 was 2.62.


The historical rank and industry rank for Afrocentric Investment's 5-Year Yield-on-Cost % or its related term are showing as below:

JSE:ACT' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.48   Med: 3.78   Max: 7.8
Current: 2.62


During the past 13 years, Afrocentric Investment's highest Yield on Cost was 7.80. The lowest was 1.48. And the median was 3.78.


JSE:ACT's 5-Year Yield-on-Cost % is ranked better than
52.29% of 262 companies
in the Healthcare Providers & Services industry
Industry Median: 2.39 vs JSE:ACT: 2.62

Competitive Comparison of Afrocentric Investment's 5-Year Yield-on-Cost %

For the Medical Care Facilities subindustry, Afrocentric Investment's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment's 5-Year Yield-on-Cost % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's 5-Year Yield-on-Cost % falls into.



Afrocentric Investment 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Afrocentric Investment is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Afrocentric Investment  (JSE:ACT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Afrocentric Investment 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Afrocentric Investment (JSE:ACT) Business Description

Traded in Other Exchanges
N/A
Address
37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.

Afrocentric Investment (JSE:ACT) Headlines